Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2337/dc21-1113
PubMed Identifier: 35100355
Publication URI: http://europepmc.org/abstract/MED/35100355
Type: Journal Article/Review
Volume: 45
Parent Publication: Diabetes care
Issue: 4
ISSN: 0149-5992